.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
UBS
Colorcon
Accenture
Covington
Cantor Fitzgerald
Cerilliant
Dow
Chubb
Harvard Business School

Generated: November 19, 2017

DrugPatentWatch Database Preview

Ioxaglate meglumine; ioxaglate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ioxaglate meglumine; ioxaglate sodium and what is the scope of ioxaglate meglumine; ioxaglate sodium patent protection?

Ioxaglate meglumine; ioxaglate sodium
is the generic ingredient in one branded drug marketed by Guerbet and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for ioxaglate meglumine; ioxaglate sodium

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 2,445
Drug Prices:see low prices
DailyMed Link:ioxaglate meglumine; ioxaglate sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Guerbet
HEXABRIX
ioxaglate meglumine; ioxaglate sodium
INJECTABLE;INJECTION018905-002Jul 26, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ioxaglate meglumine; ioxaglate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Guerbet
HEXABRIX
ioxaglate meglumine; ioxaglate sodium
INJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
Guerbet
HEXABRIX
ioxaglate meglumine; ioxaglate sodium
INJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
Guerbet
HEXABRIX
ioxaglate meglumine; ioxaglate sodium
INJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
Guerbet
HEXABRIX
ioxaglate meglumine; ioxaglate sodium
INJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Merck
Teva
Novartis
McKinsey
Medtronic
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot